A prognostic risk model for programmed cell death and revealing TRIB3 as a promising apoptosis suppressor in renal cell carcinoma
Aging · 2023
DOI: 10.18632/aging.205237 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Qingfeng Fu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China.
- Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai 264000, Shandong, China.
Zitieren
APA
Fu, Q., Yi, B., Su, Q., Huang, Y., Wang, L., & Zhang, Z. (2023). A prognostic risk model for programmed cell death and revealing TRIB3 as a promising apoptosis suppressor in renal cell carcinoma. Aging. https://doi.org/10.18632/aging.205237
Vancouver
Fu Q, Yi B, Su Q, Huang Y, Wang L, Zhang Z. A prognostic risk model for programmed cell death and revealing TRIB3 as a promising apoptosis suppressor in renal cell carcinoma. Aging. 2023. doi:10.18632/aging.205237
BibTeX
@article{Fu2023,
author = {Fu, Qingfeng and Yi, Bocun and Su, Qiang and Huang, Yue and Wang, Lin and Zhang, Zhihong},
title = {A prognostic risk model for programmed cell death and revealing TRIB3 as a promising apoptosis suppressor in renal cell carcinoma},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.205237}
}
EUVIMED